<DOC>
	<DOCNO>NCT00824837</DOCNO>
	<brief_summary>The purpose study determine whether novel haemodialysis membrane , compare standard dialysis membrane , increase removal beta2-microglobulin chronic dialysis patient .</brief_summary>
	<brief_title>Study beta2-Microglobulin Removal Standard Versus New High Cut-Off Haemodialysis Membrane</brief_title>
	<detailed_description>Despite advance treatment kidney disease , morbidity mortality chronic dialysis patient remain unsatisfactory . Standard haemodialysis membrane remove middle-sized molecule solute poorly beta2-microglobulin , pathogenic role dialysis-related amyloidosis . Pre-dialysis beta2-microglobulin concentration show independently predictive mortality . A new polyamide haemodialysis membrane develop increase pore size increase removal middle-sized uraemic toxin beta2-microglobulin . This study aim evaluate effectiveness new membrane beta2-microglobulin removal compare standard haemodialysis membrane dialysis patient degree increase loss albumin potential limiting factor use .</detailed_description>
	<criteria>Chronic haemodialysis patient 2 year Urine output &lt; 100 mL per day 3 haemodialysis session per week Permanent arteriovenous dialysis access Serum albumin &lt; 25 g/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>beta 2 microglobulin</keyword>
	<keyword>haemodialysis</keyword>
	<keyword>albumin</keyword>
</DOC>